1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Europe Prothrombin Complex Concentrate Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Europe Prothrombin Complex Concentrate Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.1.1. 3-Factor
5.2.1.2. 4-Factor
5.2.2. By End-User
5.2.2.1. Hospital
5.2.2.2. Ambulatory Services
5.2.2.3. Others
5.2.3. By Application
5.2.3.1. Acquired Coagulation Factor Deficiency
5.2.3.2. Congenital Coagulation Factor Deficiency
5.2.3.3. Others
5.2.4. By Country
5.2.4.1. Germany
5.2.4.2. United Kingdom
5.2.4.3. Italy
5.2.4.4. France
5.2.4.5. Spain
5.2.4.6. The Netherlands
5.2.4.7. Belgium
5.2.4.8. Russia
5.2.4.9. Poland
5.2.4.10. Portugal
5.2.4.11. Austria
5.2.4.12. Rest of Europe
6. Germany Prothrombin Complex Concentrate Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By End-User
6.2.3. By Application
7. United Kingdom Prothrombin Complex Concentrate Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By End-User
7.2.3. By Application
8. Italy Prothrombin Complex Concentrate Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End-User
8.2.3. By Application
9. France Prothrombin Complex Concentrate Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By End-User
9.2.3. By Application
10. Spain Prothrombin Complex Concentrate Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By End-User
10.2.3. By Application
11. The Netherlands Prothrombin Complex Concentrate Market
11.1. Market Size & Forecast by Value, 2018-2028
11.1.1. By Value (USD Million)
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By End-User
11.2.3. By Application
12. Belgium Prothrombin Complex Concentrate Market
12.1. Market Size & Forecast by Value, 2018-2028
12.1.1. By Value (USD Million)
12.2. Market Share & Forecast
12.2.1. By Type
12.2.2. By End-User
12.2.3. By Application
13. Russia Prothrombin Complex Concentrate Market
13.1. Market Size & Forecast by Value, 2018-2028
13.1.1. By Value (USD Million)
13.2. Market Share & Forecast
13.2.1. By Type
13.2.2. By End-User
13.2.3. By Application
14. Poland Prothrombin Complex Concentrate Market
14.1. Market Size & Forecast by Value, 2018-2028
14.1.1. By Value (USD Million)
14.2. Market Share & Forecast
14.2.1. By Type
14.2.2. By End-User
14.2.3. By Application
15. Portugal Prothrombin Complex Concentrate Market
15.1. Market Size & Forecast by Value, 2018-2028
15.1.1. By Value (USD Million)
15.2. Market Share & Forecast
15.2.1. By Type
15.2.2. By End-User
15.2.3. By Application
16. Austria Prothrombin Complex Concentrate Market
16.1. Market Size & Forecast by Value, 2018-2028
16.1.1. By Value (USD Million)
16.2. Market Share & Forecast
16.2.1. By Type
16.2.2. By End-User
16.2.3. By Application
17. Rest of the Europe Prothrombin Complex Concentrate Market
17.1. Market Size & Forecast by Value, 2018-2028
17.1.1. By Value (USD Million)
17.2. Market Share & Forecast
17.2.1. By Type
17.2.2. By End-User
17.2.3. By Application
18. Competitive Landscape
18.1. List of Key Players and Their Offerings
18.2. Market Share Analysis, 2021
18.3. Competitive Benchmarking, By Operating Parameters
18.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
19. Impact of COVID-19 on Europe Prothrombin Complex Concentrate Market
20. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)
20.1. CSL Behring GmbH
20.2. OCTA Pharma AG
20.3. Kedrion S.P.A.
20.4. Takeda Pharmaceuticals
20.5. China Biologic Products
20.6. Sanquin
20.7. Grifols S.A
20.8. Biotest
20.9. Abeona Therapeutics
20.10. Insud Pharma
20.11. Other Prominent Players
21. Key Strategic Recommendations
Note: Financial in information in case of non-listed companies will be provided as per availability
The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable